Li Chenglong, Pei Qian, Zhu Hong, Tan Fengbo, Zhou Zhongyi, Zhou Yuan, Li Yuqiang, Pei Haiping
Department of Gastrointestinal Surgery.
Department of Oncology, Xiangya Hospital, Central South University, Changsha, China.
Medicine (Baltimore). 2018 Dec;97(49):e13239. doi: 10.1097/MD.0000000000013239.
The postoperative survival of patients with stage III colorectal cancer (CRC) various obviously. We sought to develop novel nomograms for predicting the survival of these patients after radical surgery and postoperative chemotherapy.A total of 620 consecutive patients with stage III CRC who underwent curative resection and postoperative chemotherapy between January 2009 and December 2015 were retrospectively collected and randomly allocated to the training (n = 372) or validation cohort (n = 248). Clinicopathological factors were collected and analyzed. On the basis of data from 372 patients in the training set, predictive factors for overall survival (OS) and disease-free survival (DFS) were identified using multivariate Cox regression and used to construct nomograms. The predictive performance of the nomograms was assessed by concordance index (C-index) and calibration plots. An external cohort of 248 patients was used to validate the nomograms. Furthermore, nomogram performance was compared with the performance of T and N stage stratification.Tumor differentiation grade, lymph node metastasis ratio, intravascular emboli (IVE), preoperative serum carcinoembryonic antigen (CEA) level, albumin to globulin ratio (AGR), T stage and N stage were significant prognostic factors for OS on multivariate analysis; whereas, Tumor differentiation grade, lymph node metastasis ratio, IVE, AGR and N stage were significant for DFS. Nomograms to predict 3- and 5-year OS and DFS were established that performed well (C-indexes of 0.734 [95% CI, 0.691-0.779] for OS and 0.699 [95% CI, 0.657-0.740] for DFS prediction), and nomogram accuracy was confirmed in the validation cohort. Furthermore, model comparison proved that the nomograms were superior to risk stratification by T and N stage for stage III CRC.We propose 2 practical nomograms for stage III CRC patients that provide more accurate prognostic predictions and should be helpful for guiding individualized treatment and postoperative surveillance.
III期结直肠癌(CRC)患者的术后生存率差异显著。我们试图开发新的列线图,以预测这些患者在根治性手术和术后化疗后的生存率。回顾性收集了2009年1月至2015年12月期间连续接受根治性切除和术后化疗的620例III期CRC患者,并将其随机分配至训练队列(n = 372)或验证队列(n = 248)。收集并分析临床病理因素。基于训练集中372例患者的数据,使用多变量Cox回归确定总生存(OS)和无病生存(DFS)的预测因素,并用于构建列线图。通过一致性指数(C指数)和校准图评估列线图的预测性能。使用248例患者的外部队列验证列线图。此外,将列线图的性能与T和N分期分层的性能进行比较。多变量分析显示,肿瘤分化程度、淋巴结转移率、血管内栓子(IVE)、术前血清癌胚抗原(CEA)水平、白蛋白与球蛋白比值(AGR)、T分期和N分期是OS的显著预后因素;而肿瘤分化程度、淋巴结转移率、IVE、AGR和N分期对DFS有显著影响。建立了预测3年和5年OS及DFS的列线图,其表现良好(OS预测的C指数为0.734 [95% CI,0.691 - 0.779],DFS预测的C指数为0.699 [95% CI,0.657 - 0.740]),且在验证队列中确认了列线图的准确性。此外,模型比较证明,对于III期CRC,列线图优于T和N分期的风险分层。我们为III期CRC患者提出了2个实用的列线图,其能提供更准确的预后预测,有助于指导个体化治疗和术后监测。